Jeffrey Stein
2021
In 2021, Jeffrey Stein earned a total compensation of $1.6M as President and Chief Executive Officer at Cidara Therapeutics, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,000 |
|---|---|
| Option Awards | $794,220 |
| Salary | $565,500 |
| Other | $2,900 |
| Total | $1,630,620 |
Stein received $794.2K in option awards, accounting for 49% of the total pay in 2021.
Stein also received $268K in non-equity incentive plan, $565.5K in salary and $2.9K in other compensation.
Rankings
In 2021, Jeffrey Stein's compensation ranked 6,891st out of 12,415 executives tracked by ExecPay. In other words, Stein earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,891 out of 12,415 | 45th |
Division Manufacturing | 3,007 out of 5,508 | 45th |
Major group Chemicals And Allied Products | 1,333 out of 2,378 | 44th |
Industry group Drugs | 1,189 out of 2,099 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 281 out of 449 | 37th |
Source: SEC filing on April 29, 2022.
Stein's colleagues
We found two more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2021.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019